Semi-Annual Balance Sheet

ROHTO PHARMACEUTICAL CO.,LTD. - Filing #7295708

Concept As at
2024-09-30
As at
2024-03-31
Semi-annual balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
64,502,000,000 JPY
89,210,000,000 JPY
Other
10,001,000,000 JPY
9,773,000,000 JPY
Allowance for doubtful accounts
-377,000,000 JPY
-408,000,000 JPY
Current assets
204,895,000,000 JPY
214,759,000,000 JPY
Non-current assets
Property, plant and equipment
Property, plant and equipment
88,524,000,000 JPY
68,607,000,000 JPY
Other
Other, net
55,072,000,000 JPY
38,736,000,000 JPY
Intangible assets
Goodwill
49,531,000,000 JPY
2,285,000,000 JPY
Intangible assets
57,968,000,000 JPY
9,217,000,000 JPY
Other
8,436,000,000 JPY
6,931,000,000 JPY
Investments and other assets
Investment securities
48,009,000,000 JPY
44,337,000,000 JPY
Investments and other assets
56,871,000,000 JPY
53,590,000,000 JPY
Other
16,100,000,000 JPY
16,262,000,000 JPY
Allowance for doubtful accounts
-7,238,000,000 JPY
-7,008,000,000 JPY
Non-current assets
203,364,000,000 JPY
131,415,000,000 JPY
Assets
408,260,000,000 JPY
346,175,000,000 JPY
Liabilities
Current liabilities
Short-term borrowings
24,300,000,000 JPY
5,304,000,000 JPY
Income taxes payable
5,620,000,000 JPY
5,071,000,000 JPY
Other
32,277,000,000 JPY
29,865,000,000 JPY
Current liabilities
111,146,000,000 JPY
87,087,000,000 JPY
Non-current liabilities
Non-current liabilities
32,766,000,000 JPY
12,051,000,000 JPY
Long-term borrowings
20,236,000,000 JPY
5,190,000,000 JPY
Other
9,763,000,000 JPY
4,275,000,000 JPY
Liabilities
143,912,000,000 JPY
99,138,000,000 JPY
Other liabilities
Provision for bonuses
4,394,000,000 JPY
3,685,000,000 JPY
Other liabilities
Provision for bonuses for directors (and other officers)
25,000,000 JPY
50,000,000 JPY
Net assets
Shareholders' equity
Share capital
6,504,000,000 JPY
6,504,000,000 JPY
Capital surplus
Capital surplus
JPY
4,516,000,000 JPY
Retained earnings
Retained earnings
214,342,000,000 JPY
209,399,000,000 JPY
Treasury shares
-4,939,000,000 JPY
-4,939,000,000 JPY
Shareholders' equity
215,907,000,000 JPY
215,480,000,000 JPY
Valuation and translation adjustments
Valuation difference on available-for-sale securities
11,481,000,000 JPY
11,276,000,000 JPY
Valuation and translation adjustments
36,751,000,000 JPY
30,461,000,000 JPY
Net assets
264,347,000,000 JPY
247,036,000,000 JPY
Share acquisition rights
382,000,000 JPY
382,000,000 JPY
Liabilities and net assets
408,260,000,000 JPY
346,175,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.